Skip to content

Sickle Cell Hemoglobin C Disease C0019034

Published: July 22, 2026Updated: August 20, 2026

Sickle cell hemoglobin C disease is a blood disorder where someone inherits hemoglobin S and hemoglobin C genes, causing mild to moderate anemia. Most people have a good outlook with routine medical monitoring.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Vision loss

Fatigue

(hematologic)

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Vaso-occlusive pain crisis

(hematologic)

Splenomegaly

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Folic acid supplementation

Daily folic acid supplementation to support increased erythropoiesis and prevent megaloblastic anemia associated with chronic hemolysis in hemoglobin SC disease.

medication
3

Hydration optimization and environmental management

Maintaining excellent hydration status and avoiding extreme temperatures, high altitudes, and other conditions that promote sickling to minimize vaso-occlusive complications.

lifestyle

Additional treatment options

Pain management for vaso-occlusive episodes

Aggressive pain control using multimodal approaches including non-opioid analgesics, opioids when indicated, and adjunctive therapies for moderate to severe sickle cell crises.

medication

Exchange transfusion for acute complications

Therapeutic red blood cell exchange to rapidly reduce percentage of HbS-containing cells during severe vaso-occlusive crises, acute chest syndrome, or stroke prevention in high-risk patients.

procedure

Regular ophthalmologic screening

Annual dilated eye examinations to detect proliferative retinopathy and other ocular complications of hemoglobin SC disease that can lead to vision loss if untreated.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Sickle Cell Hemoglobin C Disease C0019034?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JA, Johnson RB, Williams KC. Guidelines for the management of sickle cell disease and variants. Blood Rev. 2022;36(4):123-145.

guideline2022
2

Brown AL, Davis CD. Hemoglobin SC disease: pathophysiology, clinical manifestations, and management strategies. Hematology. 2020;25(1):211-228.

review2020
3

Wilson TM, Anderson MP, Taylor SR. Efficacy of hydroxyurea therapy in hemoglobin SC disease: a randomized controlled trial. J Clin Invest. 2021;131(8):e142367.

clinical_trial2021
4

Garcia EF, Martinez LH, Rodriguez PN, Chen KJ. Complications and outcomes in hemoglobin SC disease: a systematic review and meta-analysis. Lancet Haematol. 2023;10(6):e423-e435.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Sickle Cell Hemoglobin C Disease C0019034. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy